BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12941423)

  • 1. New metal complexes as potential therapeutics.
    Zhang CX; Lippard SJ
    Curr Opin Chem Biol; 2003 Aug; 7(4):481-9. PubMed ID: 12941423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.
    Brabec V
    Prog Nucleic Acid Res Mol Biol; 2002; 71():1-68. PubMed ID: 12102553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum complexes as anticancer agents.
    Kostova I
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):1-22. PubMed ID: 18221023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.
    Zhao G; Lin H
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):137-47. PubMed ID: 15777221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non platinum metal complexes as anti-cancer drugs.
    Ott I; Gust R
    Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal-based antitumor compounds: beyond cisplatin.
    Simpson PV; Desai NM; Casari I; Massi M; Falasca M
    Future Med Chem; 2019 Jan; 11(2):119-135. PubMed ID: 30644327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
    Babak MV; Ang WH
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual DNA binding modes for metal anticancer complexes.
    Pizarro AM; Sadler PJ
    Biochimie; 2009 Oct; 91(10):1198-211. PubMed ID: 19344743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-lung Cancer and Anti-angiogenic Activities of New Designed Boronated Phenylalanine Metal Complexes.
    Varol M; Koparal AT; Benkli K; Bostancioglu RB
    Curr Drug Deliv; 2018; 15(10):1417-1425. PubMed ID: 30051790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-metal complexes and their potential as anticancer agents.
    Hartinger CG; Nazarov AA; Ashraf SM; Dyson PJ; Keppler BK
    Curr Med Chem; 2008; 15(25):2574-91. PubMed ID: 18855680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-based drugs.
    McQuitty RJ
    Sci Prog; 2014; 97(Pt 1):1-19. PubMed ID: 24800466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel concepts in the development of platinum antitumor drugs.
    Fuertes MA; Castilla J; Alonso C; Pérez JM
    Curr Med Chem Anticancer Agents; 2002 Jul; 2(4):539-51. PubMed ID: 12678734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
    Alama A; Tasso B; Novelli F; Sparatore F
    Drug Discov Today; 2009 May; 14(9-10):500-8. PubMed ID: 19429510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes.
    Carter R; Westhorpe A; Romero MJ; Habtemariam A; Gallevo CR; Bark Y; Menezes N; Sadler PJ; Sharma RA
    Sci Rep; 2016 Feb; 6():20596. PubMed ID: 26867983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.